SlideServe
Menu
Préférences
© SlideServe · v2026

Understanding the Impact of Inflammatory Illnesses in Primary Care Management

hyacinth-david avatar
12 diapositives · 252 Views · Nov 18, 2014

This comprehensive guide explores the significant impact of inflammatory illnesses, such as rheumatoid arthritis (RA), polyomyalgia rheumatica (PMR), and gout, on patients’ lives. With a focus on prevalence, disability rates, and complications, it emphasizes the importance of early identification and effective management strategies within primary care. We will discuss case studies and management protocols to enhance patient outcomes and mitigate the psychological and economic burdens associated with these chronic conditions.

Understanding the Impact of Inflammatory Illnesses in Primary Care Management - slide 1
01 / 12Understanding the Impact of Inflammatory Illnesses in Primary Care Management
1 / 17

Télécharger la présentation

Understanding the Impact of Inflammatory Illnesses in Primary Care Management
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. Inflammatory Illnesses

  2. Aims • Appreciate the impact of inflammatory illnesses on patients’ lives • Know how to identify and manage common inflammatory disorders in Primary Care

  3. impact

  4. Impact • Common • Gout 1.4% and RA 1% prevalence • PMR 12 new cases/yr Penistone Practice • Disability • 30% patients with RA disabled after 10 yrs • Premature mortality • Raised CVD risk, Temporal Arteritis associated with vascular complications • A 50 yr old with RA dies 4 yrs earlier than a 50 yr old without

  5. Impact • Complications • From the disease itself • From the medications (steroids, DMARDs) • Psychological well-being • 13-20% patients with RA depressed • associated with level of pain, increased functional disability,social stress and lack of social support • Fertility • Women may take longer to conceive • Medications may affect fertility

  6. Cost of Rheumatoid Arthritis estimated at £ 3.8 - 4.75 billion

  7. Mr Smith (64yrs) presents with pain in his right foot. He has Type 2 Diabetes, CKD stage 3 and drinks 34 units alcohol/week. You diagnose him as having gout. • How are you going to treat this acute flare? • Over the next 4 months he has 4 further flares: • How will you help reduce the frequency of episodes of gout?

  8. Mrs Simpson (79 yrs) presents c/o a 3 week hx of pains in both shoulders. You suspect she may have PMR and check some blood tests. • What investigations do you request? • How will you treat Mrs Simpson if ixn suggest PMR? • Is there anything else to consider?

  9. Mr Senior (82 yrs) comes to see you a day after presenting to a colleague with a right sided headache. Your colleague checked some blood tests as he thought a diagnosis of GCA was a possibility: CRP 18, ESR 28. His headache has got slightly worse since then and he c/o feeling “rotten”. • What is your plan?

  10. Miss Sampson (43 yrs) presents c/o a 6 week hx of painful,stiff joints in the hands. On examination she clinically has evidence of synovitis of the small joints. She is desperate for some good pain relief as co-codamol and ibuprofen have not helped so far. You suspect she may have an inflammatory arthritis, possibly RA. • What tests might you request? • How will you treat her pain? • What referral will you make, if any, at this point?

  11. Miss Sampson has now been on Methotrexate for 6 months for her RA and has attended today for her Annual Review. • What aspects of Miss Sampson’s care should you cover? • What 2 additional factors does the Quality Outcomes Framework specify that you cover?

  12. dsDNA Jo-1 Ro (SS-A) La (SS-B) Sm (Smith) Anti-CCP Scl-70/Centromere U1RNP Scleroderma Rheumatoid Arthritis SLE Mixed Connective Tissue Disease Sjogren’s Syndrome Polymyositis/Dermatomyositis Match the antibody to the illness